KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
Clin Mol Hepatol. 2018;24(3):230-277.   Published online 2018 Jul 9     DOI: https://doi.org/10.3350/cmh.2018.1005
Citations to this article as recorded by Crossref logo
Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence
Jingqiao Zhang, Martin Rössle, Xinmiao Zhou, Jiao Deng, Lu Liu, Xingshun Qi
Current Medical Research and Opinion.2019; 35(5): 859.     CrossRef
Estimation of renal function in patients with liver cirrhosis: Impact of muscle mass and sex
Jeong-Ju Yoo, Sang Gyune Kim, Young Seok Kim, Bora Lee, Min Hee Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Hong Soo Kim, Young Don Kim, Gab Jin Cheon
Journal of Hepatology.2019; 70(5): 847.     CrossRef
The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis
Suhyun Park, Seon In Hwang, Jonghun Kim, Seoyeon Hwang, Sohee Kang, Sera Yang, Jonghwa Kim, Wonseok Kang, Kyun-Hwan Kim, Dong Wook Han, Yong-Han Paik
Stem Cell Research & Therapy.2019;[Epub]     CrossRef
2017 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines for Ascites and Related Complications: What Has Been Changed from the 2011 KASL Clinical Practice Guidelines?
Yeon Seok Seo
The Korean Journal of Gastroenterology.2018; 72(4): 179.     CrossRef
Prognosis of Spontaneous Bacterial Peritonitis in Hepatocellular Carcinoma Patients
Jeong Han Kim, Won Hyeok Choe, So Young Kwon, Byung-chul Yoo
Journal of Korean Medical Science.2018;[Epub]     CrossRef